Shanghai - Delayed Quote CNY
GemPharmatech Co., Ltd. (688046.SS)
11.37
+0.06
+(0.53%)
At close: 3:00:04 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
700,605.34
686,837.01
622,186.99
516,547.58
393,787.17
Cost of Revenue
270,754.55
261,052.21
201,519.09
147,818.35
101,087.12
Gross Profit
429,850.79
425,784.80
420,667.90
368,729.23
292,700.04
Operating Expense
300,977.10
303,436.13
254,321.41
197,110.03
142,112.19
Operating Income
128,873.69
122,348.67
166,346.50
171,619.20
150,587.85
Net Non Operating Interest Income Expense
9,290.57
9,889.91
14,147.83
13,644.86
2,467.36
Pretax Income
121,684.06
119,215
161,287.73
173,681.59
143,314.61
Tax Provision
11,363.38
9,395.18
2,373.67
9,016.13
18,387.14
Net Income Common Stockholders
110,320.68
109,819.82
158,914.06
164,665.45
124,927.46
Basic EPS
0.27
0.27
0.39
0.42
0.35
Diluted EPS
0.27
0.27
0.39
0.42
0.35
Basic Average Shares
408,528.84
406,740.07
407,471.96
392,060.60
356,935.61
Diluted Average Shares
408,528.84
406,740.07
407,471.96
392,060.60
356,935.61
Total Operating Income as Reported
121,830.56
119,367.81
163,687.87
173,953.41
143,264.92
Total Expenses
571,731.65
564,488.34
455,840.49
344,928.37
243,199.31
Net Income from Continuing & Discontinued Operation
110,320.68
109,819.82
158,914.06
164,665.45
124,927.46
Normalized Income
130,410.71
130,608.80
186,905.51
185,801.57
142,987.38
Interest Income
12,751.38
14,388.67
17,133.64
14,243.31
3,312.17
Interest Expense
4,399.22
4,300.85
2,761.67
495.53
744.85
Net Interest Income
9,290.57
9,889.91
14,147.83
13,644.86
2,467.36
EBIT
126,083.27
123,515.85
164,049.40
174,177.11
144,059.46
EBITDA
126,083.27
208,364.93
217,781.35
213,245.25
172,873.06
Reconciled Cost of Revenue
270,754.55
261,052.21
201,519.09
147,818.35
101,087.12
Reconciled Depreciation
--
84,849.08
53,731.94
39,068.13
28,813.61
Net Income from Continuing Operation Net Minority Interest
110,320.68
109,819.82
158,914.06
164,665.45
124,927.46
Total Unusual Items Excluding Goodwill
-22,159.37
-22,567.50
-28,409.55
-22,293.41
-20,718.02
Total Unusual Items
-22,159.37
-22,567.50
-28,409.55
-22,293.41
-20,718.02
Normalized EBITDA
148,242.65
230,932.43
246,190.90
235,538.66
193,591.08
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-2,069.34
-1,778.52
-418.10
-1,157.29
-2,658.10
12/31/2021 - 4/25/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade